What is Mollie Jan's NPI number?

Mollie Jan's National Provider Identifier (NPI) is 1801072855, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Mollie Jan's specialty?

Mollie Jan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Mollie Jan located?

Mollie Jan's practice location on file with NPPES is 3010 Williams Dr Ste 210, Georgetown, TX 78628-2787.

What is Mollie Jan's phone number?

The practice phone number listed in the NPPES registry for Mollie Jan is (512) 756-2525.

Does Mollie Jan accept Medicare?

Mollie Jan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Mollie Jan's NPI active?

Yes — Mollie Jan's NPI (1801072855) is active in the NPPES registry as of the last update on 2013-02-05.

IndividualActiveAccepts Medicare

Mollie Jan, D.O.

NPI 1801072855 · Dermatology Physician · Georgetown, TX

Mollie Jan, D.O. is a Dermatology Physician provider in Georgetown, TX (NPI 1801072855).

Provider details

NPI number: 1801072855
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: D.O.
Sex: Female
Sole proprietor: No
License: OT011014 (PA)

Practice location

3010 Williams Dr Ste 210

Georgetown, TX 78628-2787

Phone: (512) 756-2525

Fax: (512) 756-2533

Street-level locationGet directions

More TX providers

Mailing address

3010 Williams Dr Ste 210

Georgetown, TX 78628-2787

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense OT011014 (PA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(90/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
18 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
6,482 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,335	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,273	$87
Destruction of Precancer Skin Growth, 1 Growth17000	761	$49
Destruction of Skin Growth, 1-14 Growths17110	608	$105
Biopsy of Related Skin Growth, First Growth11102	350	$83
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	325	237
Ketoconazole	254	142
Mupirocin	177	122
Clobetasol Propionate	157	94
Doxycycline Monohydrate	157	72
Metronidazole	119	69
Valacyclovir Hclbrand: Valacyclovir	75	41
Hydrocortisone	60

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$480 across 34 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2008-01-20
Last updated: 2013-02-05

Frequently asked questions

What is Mollie Jan's NPI number?: Mollie Jan's National Provider Identifier (NPI) is 1801072855, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Mollie Jan's specialty?: Mollie Jan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Mollie Jan located?: Mollie Jan's practice location on file with NPPES is 3010 Williams Dr Ste 210, Georgetown, TX 78628-2787.
What is Mollie Jan's phone number?: The practice phone number listed in the NPPES registry for Mollie Jan is (512) 756-2525.
Does Mollie Jan accept Medicare?: Mollie Jan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Mollie Jan's NPI active?: Yes — Mollie Jan's NPI (1801072855) is active in the NPPES registry as of the last update on 2013-02-05.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,335	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,273	$87
Destruction of Precancer Skin Growth, 1 Growth17000	761	$49
Destruction of Skin Growth, 1-14 Growths17110	608	$105
Biopsy of Related Skin Growth, First Growth11102	350	$83
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	325	237
Ketoconazole	254	142
Mupirocin	177	122
Clobetasol Propionate	157	94
Doxycycline Monohydrate	157	72
Metronidazole	119	69
Valacyclovir Hclbrand: Valacyclovir	75	41
Hydrocortisone	60

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$480 across 34 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments